Inhibidores
Los inhibidores son moléculas que se unen a enzimas, receptores u otras proteínas para reducir o bloquear su actividad biológica. Estos compuestos se utilizan ampliamente en la investigación para estudiar vías biológicas, comprender los mecanismos de las enfermedades y desarrollar fármacos terapéuticos. Los inhibidores desempeñan un papel crucial en el tratamiento de diversas enfermedades, incluyendo el cáncer, las enfermedades cardiovasculares y las infecciones. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad para apoyar su investigación en bioquímica, biología celular y desarrollo farmacéutico.
Subcategorías de "Inhibidores"
- Angiogénesis(2.524 productos)
- Apoptosis(5.793 productos)
- Ciclo celular / Checkpoint(4.452 productos)
- Cromatina / Epigenética(2.242 productos)
- Señalización citoesquelética(1.382 productos)
- Daño al ADN / Reparación del ADN(2.826 productos)
- Endocrinología / Hormonas(3.507 productos)
- Enzima(3.640 productos)
- GPCR / proteína G(8.333 productos)
- Inmunología e inflamación(3.527 productos)
- Virus de la gripe(296 productos)
- Señalización JAK / STAT(404 productos)
- Señalización MAPK(1.203 productos)
- Transportador de membrana / canal de iones(2.792 productos)
- Metabolismo(9.449 productos)
- Microbiología / Virología(6.981 productos)
- Neurociencia(9.926 productos)
- Otros inhibidores(37.921 productos)
- Reducción de oxidación(41 productos)
- Señalización PI3K / Akt / mTOR(1.400 productos)
- Proteasas / Proteasoma(1.597 productos)
- Células madre y Derivados(830 productos)
- Tirosina quinasa / adaptadores(2.015 productos)
- Ubiquitinación(1.650 productos)
Mostrar 16 subcategorías más
Se han encontrado 66639 productos de "Inhibidores"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pralatrexate, (R)-
CAS:<p>Pralatrexate is a high-affinity DHFR inhibitor targeting RFC-1, used in cancer treatment and immunosuppression.</p>Fórmula:C23H23N7O5Pureza:98%Forma y color:SolidPeso molecular:477.47Etamicastat
CAS:<p>Etamicastat can be used in the research of cardiovascular diseases.</p>Fórmula:C14H15F2N3OSPureza:98%Forma y color:SolidPeso molecular:311.35SARS 3CLpro-IN-1
CAS:<p>SARS 3CLpro-IN-1: stereospecific SARS 3CL protease inhibitor, octahydroisochromene class, IC50 = 95 μM.</p>Fórmula:C22H38N4O2Forma y color:SolidPeso molecular:390.56UCN-01
CAS:<p>inhibitor of Akt, protein kinase C, PDK1 and cyclin-dependent kinases</p>Fórmula:C28H26N4O4Pureza:98%Forma y color:SolidPeso molecular:482.53Rodatristat ethyl
CAS:<p>Rodatristat ethyl is an oral TPH1 inhibitor reducing 5-HT levels & lowering PAH at low doses.</p>Fórmula:C29H31ClF3N5O3Pureza:98%Forma y color:SolidPeso molecular:590.04PI4KIIIbeta-IN-11
CAS:<p>PI4KIIIbeta-IN-11 is a PI4KIIIβ inhibitor (mean pIC50=9.1) that can be used to study diseases caused by RNA viruses and Plasmodium falciparum.</p>Fórmula:C33H39N7O3Forma y color:SolidPeso molecular:581.71PD 135158
CAS:<p>PD 135158 is a CCK2 receptor antagonist.</p>Fórmula:C42H61N5O11Pureza:98%Forma y color:SolidPeso molecular:811.96L-97-1
CAS:<p>L-97-1 is an antagonist of the adenosine A1 receptor.</p>Fórmula:C29H38N6O3Pureza:98%Forma y color:SolidPeso molecular:518.65Antiviral agent 15
<p>Compound 15f, a Clofazimine derivative, inhibits rabies (EC50: 1.45 μM) and SARS-CoV-2 (EC50: 14.6 μM).</p>Fórmula:C27H24FN5OForma y color:SolidPeso molecular:453.51hCAII-IN-3
<p>hCAII-IN-3 inhibits key hCA isoforms with Ki: hCA I (403.8 nM), hCA II (5.1 nM), hCA IX (10.2 nM), hCA XII (5.2 nM); shows anticancer potential.</p>Fórmula:C17H21N3O3SForma y color:SolidPeso molecular:347.43RO5101576
CAS:<p>RO5101576 is a potent antagonist of LTB4 receptor.</p>Fórmula:C36H38O8SPureza:98%Forma y color:SolidPeso molecular:630.75Lamivudine, (+/-)-trans-
CAS:<p>Lamivudine, a drug for HIV-1 and HBV, inhibits reverse transcriptase and resembles zalcitabine.</p>Fórmula:C8H11N3O3SPureza:98%Forma y color:SolidPeso molecular:229.26Unoprostone
CAS:<p>Unoprostone is a prostaglandin F2α analogs (PGAs), and reduces intraocular pressure and is used topically for glaucoma or ocular hypertension.</p>Fórmula:C22H38O5Pureza:98%Forma y color:SolidPeso molecular:382.53FT3967385
<p>FT3967385: New USP30 inhibitor boosts mitochondrial ubiquitylation via PINK1-PARKIN.</p>Fórmula:C21H19N5O2Forma y color:SolidPeso molecular:373.41Antibacterial agent 66
<p>Compound 6q, a trifluoromethylpyridine oxadiazole, targets Xanthomonas oryzae with EC50 of 7.2 μg/mL.</p>Fórmula:C17H10ClF6N3O2SForma y color:SolidPeso molecular:469.79B026
CAS:<p>B026: Oral p300/CBP HAT inhibitor, IC50: p300 1.8 nM, CBP 9.5 nM; targets AR+ prostate cancer cells.</p>Fórmula:C27H23F4N5O4Forma y color:SolidPeso molecular:557.5Kinamycin B
CAS:<p>Kinamycin B is an antibacterial agent with anticancer activity.</p>Fórmula:C20H16N2O8Pureza:98%Forma y color:SolidPeso molecular:412.35BTK-IN-16
CAS:<p>BTK-IN-16 is a potential inhibitor of wild-type BTK and C481S mutants.BTK-IN-16 can be used to study various autoimmune diseases and cancers caused by BTK.</p>Fórmula:C15H14N4O2Pureza:99.04%Forma y color:SoildPeso molecular:282.3Flurdihydroergotamine
CAS:<p>Flurdihydroergotamine, a serotonin 5HT1 receptor agonist, is used as an antimigraine drug.</p>Fórmula:C34H36F3N5O5Pureza:98%Forma y color:SolidPeso molecular:651.68JAK1/TYK2-IN-3
<p>JAK1/TYK2-IN-3, orally active, selectively inhibits TYK2 (IC50: 6 nM), JAK1 (37 nM), JAK2 (140 nM), JAK3 (362 nM), and has anti-inflammatory effects.</p>Forma y color:SolidDemethoxyviridin
CAS:<p>Demethoxyviridin inhibits mammalian Ptdlns 3-kinase (p110) and is antifungal.</p>Fórmula:C19H14O5Pureza:98%Forma y color:SolidPeso molecular:322.31Prohibitin ligand 1
<p>Compound 22i, a prohibitin ligand, protects the heart at nanomolar levels by inducing STAT3 phosphorylation.</p>Fórmula:C20H22N2OForma y color:SolidPeso molecular:306.4Dyrk1A/α-synuclein-IN-1
<p>Dyrk1A/α-synuclein-IN-1 (Compound b1) is a dual inhibitor of Dyrk1A (IC50: 177 nM) and α-synuclein aggregation (IC50: 10.5 μM).</p>Fórmula:C20H21N5O3SForma y color:SolidPeso molecular:411.482R,4S-Sacubitril
CAS:<p>2R,4S-Sacubitril (Sacubitril Enantiomer) is the impurity of Sacubitril which is a neprilysin inhibitor.</p>Fórmula:C24H28NO51CaPureza:98%Forma y color:SolidPeso molecular:430.49RDN2150
CAS:<p>RDN2150 (Compound 25), a ZAP-70 inhibitor with an IC50 of 14.6 nM, covalently binds to the C346 residue of ZAP-70, suppressing the expression of CD25 and CD69</p>Fórmula:C28H29ClN8O4Forma y color:SolidPeso molecular:577.03Glyphosate-trimesium
CAS:<p>Glyphosate-trimesium is a herbicide.</p>Fórmula:C6H16NO5PSForma y color:SolidPeso molecular:245.23LY210073
CAS:<p>LY210073 is an antagonist of the Leukotriene B4 (LTB4) receptor (IC50: 6.2 nM).</p>Fórmula:C30H28O8Pureza:98%Forma y color:SolidPeso molecular:516.54GSK 932121
CAS:<p>GSK 932121: potent antimalarial, targets P. falciparum by inhibiting cytochrome bc1 in the electron transport chain.</p>Fórmula:C20H15ClF3NO4Pureza:98%Forma y color:SolidPeso molecular:425.79Ici D1542
CAS:<p>Ici D1542: potent TXS inhibitor & TXA2 receptor antagonist, effective thromboxane blocker in vitro.</p>Fórmula:C25H30N2O7Pureza:98%Forma y color:SolidPeso molecular:470.51CB-7646
CAS:<p>CB-7646 is a stable trimelamol (TM) analogue, which is an antitumor agent.</p>Fórmula:C8H16N6O2Forma y color:SolidPeso molecular:228.25KDOAM-25 trihydrochloride (2230731-99-2 free base)
<p>KDOAM-25 trihydrochloride, a selective KDM5 inhibitor (IC50: 19-71 nM), boosts H3K4 methylation and hinders MM1S cell growth.</p>Fórmula:C15H28Cl3N5O2Pureza:98%Forma y color:SolidPeso molecular:416.77PD-L1-IN-1
<p>PD-L1-IN-1, potent PD-L1 inhibitor with 115 nM IC50, suppresses tumors, boosts immune response, and spares healthy cells.</p>Fórmula:C21H23N5O2Forma y color:SolidPeso molecular:377.44MEK1/2-IN-2
<p>MEK1/2-IN-2 is a potent, ATP-competitive MEK1/2 inhibitor that exhibits equal inhibitory effects on wild-type MEK1/2 and a group of MEK1/2 mutant cells.</p>Fórmula:C28H22ClFN6OForma y color:SolidPeso molecular:512.97ST362
CAS:<p>ST362, an anticancer agent, acts by disrupting DNA repair and halting growth in prostate, colon, lung and breast cancer cells.</p>Fórmula:C25H21NO6SPureza:98%Forma y color:SolidPeso molecular:463.5α-Glucosidase-IN-14
<p>α-Glucosidase-IN-14 is a potent inhibitor of α-glucosidase (IC50: 5.22 μM).</p>Fórmula:C24H27N5O4S2Forma y color:SolidPeso molecular:513.63(R)-Atuveciclib
CAS:<p>Atuveciclib (BAY-1143572) is a potent and highly selective, oral PTEFb / CDK9 inhibitor that inhibits CDK9 / CycT1 with an IC 50 of 13 nM [1].</p>Fórmula:C18H18FN5O2SPureza:98%Forma y color:SolidPeso molecular:387.43IRAK4-IN-14
CAS:<p>IRAK4-IN-14 is a selective, potent, orally active IRAK4 inhibitor (IC50: 0.003 μM) with favorable PK parameters in rats and mice. effect.</p>Fórmula:C25H28FN9OForma y color:SolidPeso molecular:489.55BI-207524
CAS:<p>BI-207524 is a novel NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection.</p>Fórmula:C35H36ClN5O5Forma y color:SolidPeso molecular:642.14Monoamine oxidase/Aromatase-IN-1
<p>Compound 2q: Dual MAO/aromatase inhibitor; IC50: 39 nM (MAO-B), 31 nM (aromatase). Useful in neurological/breast cancer research.</p>Fórmula:C19H19N3O3SForma y color:SolidPeso molecular:369.4418-Deoxyherboxidiene
CAS:<p>18-Deoxyherboxidiene (RQN-18690A) inhibits angiogenesis, targeting SF3b in U2 snRNP spliceosome, affects HUVEC, useful for cancer research.</p>Fórmula:C25H42O5Forma y color:SolidPeso molecular:422.6CYP1B1-IN-2
<p>CYP1B1-IN-2 (compound 9j) is a highly potent and selective inhibitor of CYP1B1, a cytochrome P450 enzyme. It exhibits an IC50 value of 0.52 nM [1].</p>Fórmula:C20H11F3O2Forma y color:SolidPeso molecular:340.3FCE-24379
CAS:<p>FCE-24379 is a selective antagonist of vascular serotonin receptors that has been shown to lowers blood pressure in hypertensive rats.</p>Fórmula:C20H22N4O2Forma y color:SolidPeso molecular:350.41Anticancer agent 35
<p>Compound 10, a sulfonylurea, inhibits A549, A431, PACA2 cells with IC50s: 18.1, 4.0, 18.9 μg/mL.</p>Fórmula:C15H13N3O3S3Forma y color:SolidPeso molecular:379.48STA-1474
CAS:<p>STA-1474, a soluble prodrug of ganetespib (STA-9090), becomes a strong HSP90 inhibitor effective against canine tumors.</p>Fórmula:C20H21N4O6PForma y color:SolidPeso molecular:444.38Homodestcardin
CAS:<p>Homodestcardin: cyclic depsipeptide from T. roseum with immunosuppressant properties; inhibits mouse T cell proliferation.</p>Fórmula:C32H55N5O7Forma y color:SolidPeso molecular:621.81Metoquizine
CAS:<p>Metoquizine is an anticholinergic compound. It is a muscarinic acetylcholine receptor antagonist that has been used to treat ulcers.</p>Fórmula:C22H27N5OPureza:98%Forma y color:SolidPeso molecular:377.48IRAK4-IN-18
<p>IRAK4-IN-18: Potent IRAK4 inhibitor (IC50: 15 nM), reduces IL23 in cells, prevents rat arthritis.</p>Fórmula:C24H25FN6O3Forma y color:SolidPeso molecular:464.49HBV-IN-11
CAS:<p>HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM).</p>Fórmula:C21H24ClNO6Forma y color:SolidPeso molecular:421.87TIM-3-IN-1
<p>TIM-3-IN-1 is a useful tool to enable further studies on the biology of TIM-3 immunoregulation in cancer.</p>Fórmula:C20H16ClN7O3SForma y color:SolidPeso molecular:469.9SAR-114137
CAS:<p>SAR-114137 is a histone sphingomyelin kinase inhibitor used in the study of molluscum arteriosum and peripheral neuropathic pain.</p>Fórmula:C25H34N4O7SPureza:99.09% - 99.91%Forma y color:SolidPeso molecular:534.63SARS-CoV-2 nsp14-IN-2
<p>SARS-CoV-2 nsp14-IN-2: Strong Nsp14 methyltransferase inhibitor (IC50: 0.09 μM), potential for COVID-19 research.</p>Fórmula:C21H21N5O5SForma y color:SolidPeso molecular:455.49MDL-43291
CAS:<p>MDL-43291 is a leukotriene receptor antagonist.</p>Fórmula:C25H42O4SForma y color:SolidPeso molecular:438.66LY367385 hydrochloride
CAS:<p>LY367385 hydrochloride: selective mGluR1a antagonist, IC50 = 8.8 μM, neuroprotective, anticonvulsant, antiepileptic.</p>Fórmula:C10H12ClNO4Forma y color:SolidPeso molecular:245.66DSP-1053 benzenesulfonate
CAS:<p>DSP-1053: Benzylpiperidine-based, potent SERT inhibitor (Ki=1.02nM), partial 5-HT1A receptor agonist (Ki=5.05nM), antidepressant.</p>Fórmula:C32H38BrNO7SForma y color:SolidPeso molecular:660.62TCMDC-136230
<p>TCMDC-136230 is a novel inhibitor of Plasmodium calcium kinetics with minimal inhibition of haemoglobin crystallisation.</p>Fórmula:C24H34N4O2SForma y color:SolidPeso molecular:442.62TLR4/NF-κB/MAPK-IN-1
CAS:<p>TLR4/NF-κB/MAPK-IN-1 is a novel antineuroinflammatory agent that functions by inhibiting the TLR4/NF-κB/MAPK pathways.</p>Fórmula:C19H25BrO6Forma y color:SolidPeso molecular:429.3PrCP-7414
CAS:<p>PrCP-7414 is a potent PrCP inhibitor, CAS# 1252037-41-4, named after the CAS number's last four digits.</p>Fórmula:C31H33Cl2N5O2Forma y color:SolidPeso molecular:578.53IAB15
CAS:<p>IAB15 is a potent inhibitor of T-type calcium channel that can be used in the research of epilepsy [1].</p>Fórmula:C15H14F3NO2Forma y color:SolidPeso molecular:297.27AGN-204396
CAS:<p>AGN-204396 is an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides).</p>Fórmula:C32H44FN3O4Forma y color:SolidPeso molecular:553.71TIY-7
<p>TIY-7 is a selective, orally active inhibitor of the promyosin receptor kinase (TRK) enzyme. TIY-7 exhibited anti-tumour effects in a mouse xenograft model.</p>Forma y color:SolidRWJ-56110
CAS:<p>protease-activated receptor-1 (PAR1) antagonist</p>Fórmula:C41H43Cl2F2N7O3Pureza:98%Forma y color:SolidPeso molecular:790.73Ledene
CAS:<p>Ledene (Viridiflorene) is an essential oil produced by viridiflorene synthase.</p>Fórmula:C15H24Pureza:98%Forma y color:SolidPeso molecular:204.35SPR719
CAS:<p>SPR719 is an inhibitor of gyrase B, has bactericidal activity.</p>Fórmula:C21H25FN6O3Pureza:98%Forma y color:SolidPeso molecular:428.46Lometrexol disodium
CAS:<p>Lometrexol disodium: Inhibits hSHMT1/2 and GARFT, anticancer by blocking purine synthesis, induces apoptosis and cell cycle arrest.</p>Fórmula:C21H23N5Na2O6Forma y color:SolidPeso molecular:487.424AT1R antagonist 2
<p>AT1R antagonist 2 is a potent AT1R selective ligand with good AT1R affinity (Ki: 26 nM).</p>Fórmula:C29H37N5O4S2Forma y color:SolidPeso molecular:583.77PF 03709270
CAS:<p>PF 03709270 is an oral prodrug of sulopenem with broad-spectrum antibacterial effects on gram-positive and gram-negative bacteria.</p>Fórmula:C19H27NO7S3Pureza:98%Forma y color:SolidPeso molecular:477.61PPARγ agonist 2
<p>PPARγ agonist 2 is a highly effective compound that acts as a partial agonist for PPARγ.</p>Fórmula:C24H20O5Forma y color:SolidPeso molecular:388.41TP-030-2
CAS:<p>TP-030-2 is a RIPK1 inhibitor (human K i =0.43 nM ; mouse IC 50 =100 nM) .</p>Fórmula:C23H21BrN4O3Forma y color:SolidPeso molecular:481.34Naltrindole
CAS:<p>Naltrindole is a delta opioid receptor antagonist.</p>Fórmula:C26H26N2O3Forma y color:SolidPeso molecular:414.5GSK852
<p>GSK852 is a potent, second bromodomain (BD2)-selective, bromo and extra-terminal domain (BET) inhibitor with pIC50 of 7.9.</p>Fórmula:C24H26N2O4Forma y color:SolidPeso molecular:406.47Xylarianaphthol-1
CAS:<p>Xylarianaphthol-1 is an activator of p21 promoter in a p53-independent manner.</p>Fórmula:C16H20BrFN2O2Forma y color:SolidPeso molecular:371.24RIPK1-IN-14
CAS:<p>RIPK1-IN-14 inhibits RIPK1 with 92 nM IC50 and reduces necrotic apoptosis in U937 cells.</p>Forma y color:Soild1,9-Dideoxyforskolin
CAS:<p>The compound is an inactive analog of forskolin(an adenylyl cyclase activator).</p>Fórmula:C22H34O5Pureza:98%Forma y color:SolidPeso molecular:378.5OICR12694
CAS:<p>OICR12694 (JNJ-65234637) is an orally active inhibitor of B cell lymphoma 6 (BCL6) .</p>Fórmula:C29H28ClF3N8O4Forma y color:SolidPeso molecular:645.03NPEC-caged-(S)-3,4-DCPG
CAS:<p>mGlu8a agonist</p>Fórmula:C19H16N2O10Pureza:98%Forma y color:SolidPeso molecular:432.34HIF-1α-IN-4
<p>HIF-1α-IN-4 is an inhibitor of HIF-1α with IC50 of 24 nM in HEK293T cells which has potential antitumor effects.</p>Fórmula:C16H12N2O3Forma y color:SolidPeso molecular:280.28Mcl-1 inhibitor 9
CAS:<p>Mcl-1 Inhibitor 9 (Example 2) is a potent inhibitor of myeloid cell leukemia 1 (Mcl-1), demonstrating anti-tumor activity with an IC50 value of 0.21889 nM.</p>Fórmula:C32H39ClN2O5SForma y color:SolidPeso molecular:599.18LHC-165
CAS:<p>LHC-165 is an agonist of TLR7. It also has the potential to treat solid tumors.</p>Fórmula:C29H32F2N3O7PPureza:98%Forma y color:SolidPeso molecular:603.55BF-168
CAS:<p>BF-168 is a candidate probe for PET and specifically recognizes both neuritic and diffuse plaques (Ki: 6.4 nM for Aβ1-42).</p>Fórmula:C18H17FN2O2Forma y color:SolidPeso molecular:312.34K-14585
CAS:<p>K-14585 blocks PAR(2), reduces NFkappaB activity, and IL-8 response, but alone can boost IL-8.</p>Fórmula:C51H56Cl2N8O4Forma y color:SolidPeso molecular:915.95Deoxyfuconojirimycin hydrochloride
CAS:<p>Deoxyfuconojirimycin hydrochloride acts as a specific competitive inhibitor targeting human liver α-L-fucosidase.</p>Fórmula:C6H14ClNO3Forma y color:SolidPeso molecular:183.63Detoxin D1
CAS:<p>Detoxin D1 is a selective blasticidin S antagonist.</p>Fórmula:C28H41N3O8Pureza:98%Forma y color:SolidPeso molecular:547.64CDK8-IN-11 hydrochloride
<p>CDK8-IN-11 HCl: potent, selective CDK8 inhibitor (IC50: 46 nM), blocks WNT/β-catenin pathway, used in colon cancer research.</p>Fórmula:C19H16ClF3N4O2Forma y color:SolidPeso molecular:424.8DMGF
CAS:<p>DMGF, a biflavonoid from Taxus, induces apoptosis, autophagy, and inhibits B16F10 cell motility and MMP-2 expression, hindering melanoma metastasis.</p>Fórmula:C32H22O10Forma y color:SolidPeso molecular:566.51MK-3402
CAS:<p>MK-3402 is a metallo-beta-lactamase inhibitor. MK-3402can be used in the research of bacteria .</p>Fórmula:C15H19N9O5S2Forma y color:SolidPeso molecular:469.50Kri 1314
CAS:<p>Kri 1314 is a cyclohexyl-norstatine-containing dipeptide renin inhibitor which has potential for the treatment of hypertension.</p>Fórmula:C38H51N5O7Forma y color:SolidPeso molecular:689.84COX-2-IN-10
<p>COX-2-IN-10 is a potent COX-2 inhibitor, reducing IL-6, TNF-α, IL-1β, PGE2 (IC50=2.54 μM), and iNOS expression.</p>Fórmula:C31H32FN5O2SForma y color:SolidPeso molecular:557.68TAK-915
CAS:<p>TAK-915: potent, brain-ready PDE2A inhibitor, 0.61 nM IC50, 4100x selectivity over PDE1A.</p>Fórmula:C19H18F4N4O5Pureza:98%Forma y color:SolidPeso molecular:458.36HPK1-IN-3
<p>HPK1-IN-3: Selective HPK1 inhibitor, ATP-competitive, IC50=0.25nM; boosts IL-2 in PBMCs, EC50=108nM.</p>Fórmula:C23H22F4N6O2Forma y color:SolidPeso molecular:490.45BET-IN-8
<p>BET-IN-8 (Compound 27) is a potent inhibitor of BET (Ki: 0.83 μM, Kd: 0.571 μM), which ameliorates LPS-induced sepsis in vivo.BET-IN-8 has shown potential in</p>Fórmula:C22H21N3O4SForma y color:SolidPeso molecular:423.48D1R antagonist 1
CAS:<p>Compound 12a (D1R antagonist 1) is a D1R antagonist that participates in both G-protein-coupled and β-arrestin-mediated signaling pathways [1].</p>Fórmula:C22H26BrNO4Pureza:98%Forma y color:SolidPeso molecular:448.35A1/A3 AR antagonist 1
<p>Compound 10 is a potent dual A1/A3 AR antagonist, with Ki values of 37.6 nM (hA1), 25.4 nM (hA3), and 1.47 nM (rA1), studied in renal, lung, and Alzheimer's.</p>Fórmula:C24H18N2O3SForma y color:SolidPeso molecular:414.48HPK1-IN-14
CAS:<p>HPK1-IN-14 is a potent inhibitor of HPK1. HPK1-IN-14 has potential for the study of HPK1-related diseases.</p>Fórmula:C24H23FN6O2Forma y color:SolidPeso molecular:446.48RAD51-IN-5
CAS:<p>RAD51-IN-5 blocks RAD51; may aid mitochondrial disorder research. (WO2021164746A1, cmpd 3)</p>Fórmula:C26H38N4O5S2Forma y color:SolidPeso molecular:550.73Pegcantratinib
CAS:<p>Pegcantratinib is a tropomyosin receptor kinase inhibitor for treatment for inherited CYLD defective skin tumours.</p>Fórmula:C32H28N4O7Forma y color:SolidPeso molecular:580.59TGR5 Receptor Agonist 3
CAS:<p>TGR5 Receptor Agonist 3 is a GPBAR1 agonist with EC50 of 16.4 nM (hTGR5) & 209 nM (mTGR5), ensures gallbladder safety and reduces filling.</p>Fórmula:C29H27N3O6Forma y color:SolidPeso molecular:513.54AChE/BuChE-IN-3
CAS:<p>AChE/BuChE-IN-3 inhibits AChE (IC50: 0.65 μM), BuChE (IC50: 5.77 μM), crosses BBB, and hinders Aβ1-42 aggregation for Alzheimer's research.</p>Fórmula:C30H30F3N3O6Forma y color:SolidPeso molecular:585.57PPARα/γ agonist 1
<p>PPARα/γ agonist 1 is a potent and dual PPARα/γ partial agonist which is a promising prototype for the research of dyslipidemia and diabetes.</p>Fórmula:C18H19NO2Forma y color:SolidPeso molecular:281.35DNDI-8219
CAS:<p>DNDI-8219 is an antitubercular agent. It has potent antileishmanial effects.</p>Fórmula:C13H10F3N3O5Forma y color:SolidPeso molecular:345.23CEP-2563
CAS:<p>CEP-2563 is a prodrug of CEP-751. It also used as an antitumor agent, inhibiting protein kinases.</p>Fórmula:C36H41ClN6O6Pureza:98%Forma y color:SolidPeso molecular:689.20MT-134
<p>MT-134 is a SkMII -specific inhibitor and has excellent exposure in muscles.</p>Fórmula:C19H16N4O3Forma y color:SolidPeso molecular:348.36AR antagonist 4
<p>AR antagonist 4 (Compound 67-b) is an orally active androgen receptor (AR) antagonist that acts on wild-type AR (IC50: 246.6 nM).</p>Fórmula:C29H36N4OForma y color:SolidPeso molecular:456.62KR-67607
CAS:<p>KR-67607, or NTX-101, is a novel 11β-HSD1 inhibitor that protects against eye injury by reducing cortisol and preserving eye structures.</p>Fórmula:C24H29Cl2F3N4O4SForma y color:SolidPeso molecular:597.48HDAC-IN-47
<p>HDAC-IN-47: Oral HDAC inhibitor (IC50: 19.75-302.73 nM for HDAC1-8), blocks G2/M, inhibits autophagy, triggers apoptosis, anti-cancer in vivo.</p>Fórmula:C17H20BrN3O4Forma y color:SolidPeso molecular:410.26Ph-Ph+
<p>Ph-Ph+ is a dimerized phenanthroline derivative with antitumor, antibacterial, and antifungal effects.</p>Fórmula:C24H17N4Forma y color:SolidPeso molecular:361.42DNA-PK-IN-6
CAS:<p>DNA-PK-IN-6 inhibits DNA-PKcs, disrupting tumor DNA repair and triggering apoptosis; enhances radiotherapy and targets various tumors (WO2021197159A1).</p>Fórmula:C19H21N7OForma y color:SolidPeso molecular:363.42Antimalarial agent 9
<p>Antimalarial 9, a quinoline-imidazole derivative, effectively targets CQ-susceptible (IC50-0.14 μM) and MDR strains (IC50-0.41 μM) with low toxicity.</p>Fórmula:C28H32BrN3O2Forma y color:SolidPeso molecular:522.48FCE-27262
CAS:<p>FCE-27262 is a prostaglandin H2/thromboxane A2 receptor antagonist.</p>Fórmula:C23H31N3O3Forma y color:SolidPeso molecular:397.51Antitumor agent-76
CAS:<p>Antitumor agent-76 is a water-soluble, orally active, rapid-release prodrug of Triptolide that exhibits anticancer effects.</p>Fórmula:C28H36ClNO10Forma y color:SolidPeso molecular:582.04RORγt Inverse agonist 2
CAS:<p>RORγt Inverse agonist 2 is a selective, orally active inverse agonist of RORγt(EC50 of 119 nM).</p>Fórmula:C27H25F8NO5SPureza:98%Forma y color:SolidPeso molecular:627.54SARS-CoV-2-IN-23
<p>SARS-CoV-2-IN-23 (compound GRL-0617) is an inhibitor of SARS-COV-2 papain-like protease (PLpro) (IC 50 = 2.3 μM) [1].</p>Fórmula:C21H22N2OForma y color:SolidPeso molecular:318.41Anticancer agent 16
<p>Anticancer agent 16 showed good cytotoxic effects on HCT-116 cell line (IC50: 8.55 μM), NCI-H460 cell line (IC50: 5.41 μM) and SKOV3 cell line (IC50: 6.4 μM).</p>Fórmula:C27H33N5O6Forma y color:SolidPeso molecular:523.58Antiangiogenic agent 2
<p>Antiangiogenic agent 2 (compound 3b) is a potent inhibitor of thymidine phosphorylase (IC50: 39.71 μM) and exhibits anti-angiogenic effects.</p>Fórmula:C26H26FN3O4Forma y color:SolidPeso molecular:463.5Tuberculosis inhibitor 5
<p>Compound 11i: potent, non-toxic anti-tuberculosis biphenyl analogue.</p>Fórmula:C25H18N2O2SForma y color:SolidPeso molecular:410.49Encephalitic alphavirus-IN-1
<p>Alphavirus-IN-1 blocks VEEV (EC50: 0.24 μM) & EEEV (EC50: 0.16 μM), non-toxic, stable in mice plasma.</p>Fórmula:C27H25FN6O2Forma y color:SolidPeso molecular:484.52Topoisomerase I/II inhibitor 3
<p>Topoisomerase I/II inhibitor 3 suppresses cell growth and induces apoptosis in liver cancer by blocking PI3K/Akt/mTOR.</p>Fórmula:C24H24N2O4Forma y color:SolidPeso molecular:404.46nNOS-IN-25
CAS:<p>nNOS-IN-25 is an effective, selective, and cell-permeable inhibitor of neuronal nitric oxide synthase.</p>Fórmula:C21H22N4Pureza:98%Forma y color:SolidPeso molecular:330.43UCN-02
CAS:<p>UCN-02 (7-epi-Hydroxystaurosporine) is a PKC inhibitor produced by Streptomyces N-126 strain, which inhibits PKA.</p>Fórmula:C28H26N4O4Pureza:98%Forma y color:SolidPeso molecular:482.53RS 61756-007
CAS:<p>RS 61756-007 is a selective thromboxane receptor (TP) agonist.</p>Fórmula:C23H28O5Pureza:98%Forma y color:SolidPeso molecular:384.47KNT-127
CAS:<p>KNT-127 is an agonist of δ-Opioid receptor.</p>Fórmula:C24H24N2O2Pureza:98%Forma y color:SolidPeso molecular:372.46BRD0418
CAS:<p>BRD0418 acts as an upregulator of TRIB1 expression by leading to reprogramming of hepatic lipoprotein metabolism from adipogenesis to clearance it.</p>Fórmula:C29H32N2O5Pureza:99.57%Forma y color:SolidPeso molecular:488.57(S)-MALT1-IN-5
CAS:<p>(S)-MALT1-IN-5: Potent MALT1 protease inhibitor, may help in abnormal T/B-cell signalling and MALT1-linked diseases.</p>Fórmula:C17H17ClF2N6O3Forma y color:SolidPeso molecular:426.80CDK1-IN-4
<p>CDK1-IN-4 inhibits CDK1 (IC50: 44.52 nM), CDK2/CDK5 less potently, impacts cell cycle, used in cancer studies.</p>Fórmula:C26H24ClN5SForma y color:SolidPeso molecular:474.02GSK699
CAS:<p>GSK699 is a potent, cell penetrant PCAF/GCN5 PROTAC.</p>Fórmula:C45H51BrN8O7Forma y color:SolidPeso molecular:895.84PD-149163
CAS:<p>PD-149163: brain-penetrating, selective NTR1 agonist; shows pro-cognitive, anti-psychotic, anxiolytic effects.</p>Fórmula:C42H71N9O6Forma y color:SolidPeso molecular:798.07Protectin D1
CAS:<p>Protectin D1 (Neuroprotectin D1) is a neuroprotectin produced by nerve cells and is a potential cardioprotective agent.</p>Fórmula:C22H32O4Pureza:99.72% - 99.79%Forma y color:SolidPeso molecular:360.49AS1940477
CAS:<p>AS1940477 selectively inhibits p38 MAPK α/β, blocks proinflammatory cytokines in cells, and has anti-inflammatory effects in rats.</p>Fórmula:C24H22FN5O2Forma y color:SolidPeso molecular:431.46KRAS inhibitor-13
CAS:<p>KRAS inhibitor-13 blocks KRAS G12C (IC50: 0.883 μM) and p-ERK in some cancer cells; promising for pancreatic, colorectal, lung cancer research.</p>Fórmula:C25H19ClFN3O2SForma y color:SolidPeso molecular:479.95GGTI298
CAS:<p>GGTI298 is a potent GGTase I inhibitor; IC50 3μM for Rap1A, >20μM for Ha-Ras.</p>Fórmula:C27H33N3O3SPureza:98%Forma y color:SolidPeso molecular:479.63KDM1/CDK1-IN-1
<p>KDM1/CDK1-IN-1 inhibits KDM1 (IC50: 0.096 μM) & CDK1 (IC50: 0.078 μM), blocks HOP-92 G2/M phase, induces apoptosis, toxic to cancer cells.</p>Fórmula:C22H17N5O3SForma y color:SolidPeso molecular:431.47Antiproliferative agent-3
<p>Antiproliferative agent-3 (comp 4) exhibits potent growth inhibitory effects against MCF-7 cells with IC 50 of 0.19 nM [1].</p>Fórmula:C11H12N2O5SForma y color:SolidPeso molecular:284.29SSR 146977
CAS:<p>NK3 receptor antagonist</p>Fórmula:C35H42Cl2N4O2Pureza:98%Forma y color:SolidPeso molecular:621.64TGFβ1-IN-1
CAS:<p>TGFβ1-IN-1 is a TGF-β1 inhibitor that inhibits the production of TGF-β1-induced fibrosis markers (α-SMA and fibronectin) and can be used in cancer research.</p>Fórmula:C22H24N2O3Pureza:99.89% - 99.89%Forma y color:SolidPeso molecular:364.438CB 30900
CAS:<p>CB30900 is a novel and effective thymidylate synthase inhibitor.</p>Fórmula:C31H32FN5O9Forma y color:SolidPeso molecular:637.61Tacrolimus anhydrous 8-epimer
CAS:<p>Tacrolimus anhydrous 8-epimer, an immunosuppressive l-pipecolic acid macrolide, blocks T cell growth by hindering IL-2.</p>Fórmula:C44H69NO12Forma y color:SolidPeso molecular:804.02Rosiptor acetate
CAS:<p>Rosiptor (AQX-1125) activates SHIP1, inhibits Akt, and reduces inflammation and allergy in rodents.</p>Fórmula:C22H39NO4Pureza:98%Forma y color:Solid PowderPeso molecular:381.55Cleistanthin
CAS:<p>Cleistanthin, a toxic Cleistanthus collinus compound, has antihypertensive, alpha-antagonist, and diuretic properties; a modified naphthofuran-xylose.</p>Fórmula:C28H28O11Forma y color:SolidPeso molecular:540.52Antileishmanial agent-5
<p>Antileishmanial agent-4, a ribonucleoside analogue, targets L.infantum and T.cruzi with EC50s of 0.68 μM and 0.83 μM.</p>Fórmula:C17H17ClN4O4Forma y color:SolidPeso molecular:376.79BMS-248360
CAS:<p>BMS-248360: Oral dual hAT1/hETA antagonist with Kis of 10nM & 1.9nM, respectively; treats hypertension.</p>Fórmula:C36H45N5O5SPureza:98%Forma y color:SolidPeso molecular:659.845-HT6/5-HT2AR antagonist-1
<p>Potent 5-HT6/5-HT2A receptors dual antagonist with K i of 11 nM & 39 nM.</p>Fórmula:C21H26N6SForma y color:SolidPeso molecular:394.54MC4355
<p>MC4355 is a dual inhibitor of EZH2 and histone deacetylase (HDAC).</p>Fórmula:C30H36N4O5Forma y color:SolidPeso molecular:532.63L 156903
CAS:<p>L 156903 is a bioactive chemical. It also inhibits the binding of neurotensin to brain tissue.</p>Fórmula:C35H41N7O5SForma y color:SolidPeso molecular:671.81AM679
CAS:<p>AM679: potent, selective FLAP inhibitor; IC50s—2.2 nM (FLAP), 0.6 nM (hLA), 154 nM (hWB); blocks leukotrienes in vivo; no significant CYP3A4 interaction.</p>Fórmula:C40H44N4O5SPureza:98%Forma y color:SolidPeso molecular:692.874-Bromo A23187
CAS:<p>4-Bromo A23187 is a halogenated analog of the calcium ionophore A-23187. 4-Bromo A23187 is a calcium modulator and induces apoptosis in different cells.</p>Fórmula:C29H36BrN3O6Pureza:98%Forma y color:SolidPeso molecular:602.52Keap1-Nrf2-IN-1 TFA
<p>Keap1-Nrf2-IN-1 TFA (compound35) is a potent inhibitor (IC50: 43 nM) protecting against acetaminophen liver damage.</p>Fórmula:C26H25F3N2O9SForma y color:SolidPeso molecular:598.54LRRK2-IN-5
<p>LRRK2-IN-5 is an oral, BBB-penetrating selective inhibitor for LRRK2 with IC50s: 1.2μM (GS) and 16μM (WT); halts LRRK2 autophosphorylation.</p>Fórmula:C24H26F2N4O2SForma y color:SolidPeso molecular:472.55AZD0424
CAS:<p>AZD0424: oral Src/Abl kinase inhibitor; potential anticancer; induces apoptosis, cell cycle arrest in lymphoma.</p>Fórmula:C25H29ClN6O5Pureza:98%Forma y color:SolidPeso molecular:528.99BRD5631
CAS:<p>BRD5631 is an autophagy enhancer, enhances autophagy through an mTOR-independent pathway.</p>Fórmula:C30H35N3O4Pureza:98%Forma y color:SolidPeso molecular:501.62LJ-4517
<p>LJ-4517 is an effective A2AAR antagonist (Ki=18.3 nM). LJ-4517 can effectively replace the binding of [3H] ZM241385 at WT A2AAR.</p>Fórmula:C19H21N5O3SForma y color:SolidPeso molecular:399.47Falecalcitriol
CAS:<p>Falecalcitriol is an analog of calcitriol. It has a higher potency both in vivo and in vitro systems, which is longer duration of action in vivo.</p>Fórmula:C27H38F6O3Pureza:98%Forma y color:SolidPeso molecular:524.58QTX125 TFA
<p>QTX125 TFA: Potent, selective HDAC6 inhibitor with antitumor effects.</p>Fórmula:C25H20F3N3O7Forma y color:SolidPeso molecular:531.44MDL-27210
CAS:<p>MDL-27210 is the ethyl ester prodrug of a potent angiotensin-converting enzyme inhibitor, MDL-27088.</p>Fórmula:C27H32N2O5Forma y color:SolidPeso molecular:464.55FGFR-IN-5
CAS:<p>FGFR-IN-5 is a potent inhibitor of FGFR. FGFR-IN-5 has potential for research in cancer diseases.</p>Fórmula:C25H22N6O3Forma y color:SolidPeso molecular:454.48SB 224289
CAS:<p>SB 224289: selective 5-HT1B antagonist, pKi 8.2, 60x selectivity, effective orally.</p>Fórmula:C32H32N4O3Pureza:98%Forma y color:SolidPeso molecular:520.62Glucosylceramide synthase-IN-3
<p>Glucosylceramide synthase-IN-3 (BZ1) is a potent, brain-accessible, oral GCS inhibitor with a 16 nM IC50, relevant for Gaucher's disease study.</p>Fórmula:C21H20FN3O3Forma y color:SolidPeso molecular:381.4SGE-516
CAS:<p>SGE516: neuroactive steroid, enhances GABAA, lowers neuronal activity, protects from seizures.</p>Fórmula:C23H35N3O2Pureza:98%Forma y color:SolidPeso molecular:385.54MRGPRX1 agonist 4
<p>Potent, oral MRGPRX1 agonist 4 modulates receptor positively (EC50: 0.1 μM) and reduces mice's thermal allergy response.</p>Fórmula:C23H17Cl2F3N2O2SForma y color:SolidPeso molecular:513.36Hoe 892
CAS:<p>Hoe 892 is a stable thia-thimo-analogue of prostacyclin and acts as a platelet aggregation inhibitor.</p>Fórmula:C20H33NO4SForma y color:SolidPeso molecular:383.55Saphenamycin
CAS:<p>Saphenamycin is an antibiotic from a strain of Streptomyces.</p>Fórmula:C23H18N2O5Pureza:98%Forma y color:SolidPeso molecular:402.40AZ-3
CAS:<p>AZ-3 is a potent and selective JAK1 inhibitor (IC50: 34 nM).</p>Fórmula:C20H28FN7Pureza:98%Forma y color:SolidPeso molecular:385.48J-104118
CAS:<p>J-104118 potentially inhibits squalene synthase.</p>Fórmula:C28H26Cl2FNO5Pureza:98%Forma y color:SolidPeso molecular:546.41Glutamate-5-kinase-IN-2
<p>Glutamate-5-kinase-IN-2 (compound 54) is a potent G5K inhibitor with 4.2 μM MIC, potential in anti-TB research.</p>Fórmula:C17H10ClFN2Forma y color:SolidPeso molecular:296.73rel-SB-612111 hydrochloride
CAS:<p>NOP receptor antagonist</p>Fórmula:C24H30Cl3NOPureza:98%Forma y color:SolidPeso molecular:454.86Tubulin inhibitor 14
<p>Tubulin inhibitor 14 blocks NQO2 and microtubule formation, disrupts blood vessels, and may target tumors; IC50 of 1.0 μM.</p>Fórmula:C15H9F2NOForma y color:SolidPeso molecular:257.23KRAS G12D inhibitor 16
CAS:<p>KRAS G12D inhibitor 16 targets KRAS G12D with IC50 of 0.7 nM and mutant form at 0.35 μM, useful in various cancer studies.</p>Fórmula:C32H39IN6O3Forma y color:SolidPeso molecular:682.59LPA5 antagonist 1
<p>LPA5 antagonist 1: selective, potent (IC50=32 nM), high brain permeability, studies inflammatory/neuropathic pain.</p>Fórmula:C28H26N2O4SForma y color:SolidPeso molecular:486.58CHK-IN-1
CAS:<p>CHK-IN-1 is a dual inhibitor of CHK1 and CHK2 with antiproliferative activity.</p>Fórmula:C18H19ClFN5OSPureza:>99.99%Forma y color:SolidPeso molecular:407.89SR 140333
CAS:<p>SR 140333 is a NK1 receptor antagonist.</p>Fórmula:C37H45Cl3N2O2Pureza:98%Forma y color:SolidPeso molecular:656.12Anticancer agent 12
<p>Anticancer agent 12 shows cytotoxic activity in malignant cells with no hepatotoxicity.</p>Fórmula:C16H17BrN4O2SForma y color:SolidPeso molecular:409.3PI3kδ inhibitor 1
CAS:<p>PI3kδ inhibitor 1 is a selective inhibitor of PI3Kδ (IC50 of 3.8 nM).</p>Fórmula:C28H33FN6O2Pureza:98%Forma y color:SolidPeso molecular:504.60PF-06305591 dihydrate
<p>PF-06305591 dihydrate is a potent and highly selective voltage gated sodium channel NaV1.8 blocker (IC 50 = 15 nM) with an excellent preclinical in vitro ADME</p>Fórmula:C15H26N4O3Forma y color:SolidPeso molecular:310.39TSWV-IN-1
<p>TSWV-IN-1 is an anti-TSWV drug with potential TSWV N.</p>Fórmula:C26H31FO4S2Forma y color:SolidPeso molecular:490.65AZD 4407
CAS:<p>AZD 4407 is a potent inhibitor of 5-lipoxygenase.</p>Fórmula:C19H21NO3S2Pureza:98%Forma y color:SolidPeso molecular:375.5PPO-IN-1
<p>PPO-IN-1 is a potent inhibitor of protoporphyrinogen IX oxidase (PPO) (Ki: 2.5 nM).</p>Fórmula:C18H10F3N3O4SForma y color:SolidPeso molecular:421.35CD33 splicing modulator 1
<p>Compound 1 modulates CD33, affects microglial cells, and may aid in neurodegenerative disease research.</p>Fórmula:C25H25FN6OForma y color:SolidPeso molecular:444.5RSV-IN-7
CAS:<p>RSV-IN-7 (example 253) is a RSV inhibitor ( EC 50 : < 0.4 μΜ) .</p>Fórmula:C27H22F3N7O3Forma y color:SolidPeso molecular:549.50METTL3-IN-2
CAS:<p>METTL3-IN-2, a potent METTL3 inhibitor, exhibits an IC50 value of 6.1 nM, effectively impairing the proliferation of Caov3 cancer cells.</p>Fórmula:C25H26N8OForma y color:SolidPeso molecular:454.53MtTMPK-IN-7
<p>MtTMPK-IN-7 inhibits MtbTMPK (IC50: 47 μM), active against M. brevis (MIC: 2.3-4.7 μM), useful for tuberculosis research.</p>Fórmula:C27H29ClN6O3Forma y color:SolidPeso molecular:521.01EGFR-IN-48
<p>EGFR-IN-48: potent EGFR inhibitor, oral, IC50: 0.193-66.7 nM, blocks EGFR mutants & BaF3/PC-9 cell proliferation.</p>Forma y color:SolidSTING agonist-20
CAS:<p>STING agonist-20: potent, aids in XMT-2056 synthesis, used as a cancer vaccine adjuvant.</p>Fórmula:C36H39N11O8Forma y color:SolidPeso molecular:753.76A-9758
CAS:<p>A-9758: RORγt selective inverse agonist, IC50 5nM, inhibits IL-17A, Th17, and treats psoriasis.</p>Fórmula:C25H23Cl2F3N2O3Pureza:98%Forma y color:SolidPeso molecular:527.36TAP311
<p>TAP311 is an inhibitor of cholesteryl ester transfer protein (CETP)(IC50 of 62 nM).</p>Fórmula:C34H40F6N6O4Pureza:98%Forma y color:SolidPeso molecular:710.71LTD4 antagonist 1
CAS:<p>LTD4 antagonist 1 is a potent and orally active antagonist of leukotriene D4 (LTD4; Ki: 0.57 nM).</p>Fórmula:C31H32F3N3O5SPureza:98%Forma y color:SolidPeso molecular:615.66WDR5-IN-5
CAS:<p>WDR5-IN-5: Selective oral inhibitor for WDR5's WIN site with high affinity (Ki<0.02 nM) and anti-cancer properties. Good pharmacokinetics.</p>Fórmula:C29H29F3N6OForma y color:SolidPeso molecular:534.58Emd 52297
CAS:<p>Emd 52297 is an inhibitor of renin.</p>Fórmula:C39H59N11O7Pureza:98%Forma y color:SolidPeso molecular:793.96RORγt/DHODH-IN-1
CAS:<p>RORγt/DHODH-IN-1 (compound (R)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.083 μM) and DHODH (IC50: 0.172 μM), which exhibits significant</p>Fórmula:C24H26ClF6N3O3SForma y color:SolidPeso molecular:585.99IMR687
CAS:<p>IMR687: a PDE9 inhibitor that could improve memory in Alzheimer's by slowing cGMP hydrolysis.</p>Fórmula:C21H26N6O2Pureza:98%Forma y color:SolidPeso molecular:394.47Tylophorinidine
CAS:<p>Tylophorinidine is an antifungal agent that has shown to inhibit cell growth.</p>Fórmula:C22H23NO4Forma y color:SolidPeso molecular:365.42NB-533
CAS:<p>NB-533 is a macrocyclic peptidic BACE-1 inhibitor.</p>Fórmula:C33H55N3O4Forma y color:SolidPeso molecular:557.81SCH 563705
CAS:<p>SCH 563705 is a CXCR2 and CXCR1 antagonist used in the study of acute respiratory syndrome, chronic obstructive pulmonary disease, and inflammation.</p>Fórmula:C23H27N3O5Pureza:98.03%Forma y color:SolidPeso molecular:425.48PRMT5-IN-19
<p>PRMT5-IN-19 is a potent, selective PRMT5 inhibitor with IC50 of 23.9 nM and 47 nM, showing anti-cancer activity by inducing apoptosis.</p>Fórmula:C25H24N4OForma y color:SolidPeso molecular:396.48Bomedemstat hydrochloride
<p>Bomedemstat (IMG-7289) hydrochloride, an oral LSD1 inhibitor, has anticancer properties, blocking cell growth and triggering apoptosis.</p>Fórmula:C28H35ClFN7O2Forma y color:SolidPeso molecular:556.08Antifungal agent 13
CAS:<p>Antifungal agent 13 demonstrates significant antifungal activity against Sclerotinia sclerotiorum, achieving an EC50 of 1.25 mg/L.</p>Fórmula:C21H16ClF3N4OForma y color:SolidPeso molecular:432.83Squalestatin 2
CAS:<p>Squalestatin 2 is an inhibitor of squalene synthase.</p>Fórmula:C33H44O13Pureza:98%Forma y color:SolidPeso molecular:648.69O-Desmethyl Midostaurin
CAS:O-Desmethyl Midostaurin is the active Midostaurin metabolite via cytochrome P450 liver enzyme metabolism.Fórmula:C34H28N4O4Pureza:98%Forma y color:SolidPeso molecular:556.61Burapitant
CAS:<p>Burapitant (SSR 240600) is a novel non-peptide tachykinin neurokinin 1 (NK) receptor antagonist with anti-coke oven and antidepressant activity.</p>Fórmula:C31H35Cl2F6N3O3Pureza:>99.99% - >99.99%Forma y color:SolidPeso molecular:682.52RWJ-445167
CAS:<p>RWJ-445167 is a thrombin and factor Xa dual inhibitor(Ki of 4.0 nM and 230 nM, respectively), with potent antithrombotic activity.</p>Fórmula:C18H24N6O5SPureza:98%Forma y color:SolidPeso molecular:436.49Ceclazepide
CAS:<p>Ceclazepide is an antagonist of cholecystokinin receptor.</p>Fórmula:C30H32N6O5Pureza:98%Forma y color:SolidPeso molecular:556.61GLS1 Inhibitor-5
<p>GLS1 Inhibitor-5 (24y): Selective, oral glutaminase 1 inhibitor; IC50 68 nM; induces apoptosis; anti-tumor.</p>Forma y color:SolidNDT-30805
<p>NDT-30805, a triazolopyridine, blocks IL-1β in PBMC (IC50: 0.013μM) & NLRP3 inflammasome, for inflammation research.</p>Fórmula:C23H22N6SForma y color:SolidPeso molecular:414.53
